BRANFORD, Conn., Oct. 2 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. , a medical device company focused on innovative, non- invasive vital signs monitoring, announced today that an abstract demonstrating the utility of the FORE-SIGHT Cerebral Oximeter in clinical studies will be presented at the upcoming American Society of Anesthesiologists (ASA) Annual Meeting in Chicago. The abstract, entitled “The Application of Absolute Cerebral Oximetry During Aortic Surgery” will be presented by Dr. Gregory Fischer of Mount Sinai Medical Center, NY on October 15, 2006 and is available on the ASA website at (http://www.asahq.org).
“We believe this data clearly demonstrates the value of absolute cerebral oximetry in identifying catastrophic events during high risk cardiovascular surgery,” commented Louis P. Scheps, President and CEO of CAS Medical Systems, Inc. “We remain on track to launch FORE-SIGHT by year end, utilizing a network of specialty distributors to sell FORE-SIGHT in the U.S.” Mr. Scheps continued, “The use of sophisticated specialty distributors with established customer relationships in the cardiovascular arena will enable CASMED to quickly penetrate key markets. This model complements our current distribution structure and allows us to expand into additional markets as we continue to gather clinical data to support broadened applications of absolute cerebral oximetry.”
About the FORE-SIGHT Cerebral Oximeter
Our initial market focus is on high risk cardiovascular surgeries, of which there are about 700,000 performed each year in the U.S. Additional market opportunities include a broad range of general surgical procedures and postoperative and critical care settings. Protecting the brain from low oxygen levels during these procedures is an important goal of every surgical team because the brain is highly vulnerable to oxygen deprivation. At normal body temperatures, damage to brain cells due to lack of oxygen can occur after just a few seconds. The FORE-SIGHT Cerebral Oximeter will provide new information to allow clinicians to monitor and respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.
For further information regarding the FORE-SIGHT product, visit the Company’s website at http://www.casmed.com/fore-sight.
About CAS Medical Systems, Inc. - CASMED(TM)
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, blood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact: CAS Medical Systems, Inc. 44 East Industrial Road Branford, CT 06405 (203) 488-6056 ir@casmed.com Investors Financial Dynamics John Capodanno 212-850-5705 jcapodanno@fd-us.com Media Financial Dynamics Robert Stanislaro 212-850-5657 rstanislaro@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s most recent Form 10-KSB and other Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc.
CONTACT: CAS Medical Systems, Inc., +1-203-488-6056, ir@casmed.com; orInvestors: John Capodanno, +1-212-850-5705, jcapodanno@fd-us.com, or Media:Robert Stanislaro, +1-212-850-5657, rstanislaro@fd-us.com, both for CASMedical Systems, Inc.
